Volume 4, 2015 | In This Issue
2015: A Year of Record Accomplishments > Distinguished Innovator Award > Hydroxychloroquine 101* A Physician Shares Her Insights > A Deeply Personal Quest > 1st Joint Scientific Meeting > Lupus News Corner >
2015: A YEAR OF RECORD ACCOMPLISHMENTS
DEFEATING LUPUS ON MANY FRONTS
Gaining ground in the fight against lupus takes incredible drive, the imagination and insights of the world's most brilliant scientists, and the backing of compassionate supporters of the Alliance for Lupus Research (ALR).
Throughout the year, the ALR combined these essential elements to gain new insights about lupus — and to find new ways to defeat the disease. Here are the highlights of 2015:
- The ALR awarded 15 scientists working in the world's most prestigious laboratories over $8.2 million in grants through our Target Identification in Lupus (TIL) program.
- We announced plans to merge with the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation. The bold new organization will be further empowered to lead the way toward new treatments and a cure. We're Moving Forward Together!
- In collaboration with the Lupus Foundation of America and the LRI, the ALR awarded the Lupus Insight Prize to George C. Tsokos, MD, Harvard Medical School. The grant acknowledges Dr. Tsokos' groundbreaking work to improve treatment for lupus nephritis.
- The ALR and the LRI launched the Lupus Clinical Investigators Network (LuCIN) to conduct clinical trials as part of an innovative program to repurpose drugs already approved by the FDA for other conditions.
- We continued our partnership with Pfizer's Centers for Therapeutic Innovation — funding critical projects at Boston Children's Hospital and the Hospital for Special Surgery.
- Participants in the ALR's Walk with Us to Cure Lupus walkathons are staunch believers that individuals can make an enormous difference — and they are right! In 2015, walkers and their families, friends, and sponsors generated nearly $3 million for ALR-funded scientific research.
- New York Jets star Willie Colon organized his first Charity Golf Outing in support of the ALR — and in honor of his mother, Jean Davis, who has lupus. The event raised more than $100,000 for critical ALR-funded research investigations.
- We partnered with the biopharmaceutical company Horizon Pharma to study a delayed release form of prednisone to explore its potential benefits as a steroid sparing treatment for lupus. This will be the first clinical trial supported by LuCIN.
- The ALR granted an additional $100,000 to the ImmunoChip project, a powerful genetics technology with the potential to uncover critical data about gene expression and the molecular pathways driving pathogenesis.
- Our Moving Forward Together to Fight Lupus Gala honored Verizon for their corporate leadership and raised $3 million for lupus research.
The ALR reached a milestone accomplishment in 2015:
The cumulative total support that the ALR awarded to
pioneering research since its inception topped $100 million.